Personal tools

DOID:0050687: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{DOID |id=DOID:0050687 |name=cell type cancer |namespace= |def="A cancer that is classified by the type of cell from which it is derived." [url:http\://cancerguide.org/ba...")
 
No edit summary
Line 2: Line 2:
|id=DOID:0050687
|id=DOID:0050687
|name=cell type cancer
|name=cell type cancer
|namespace=
|namespace=disease_ontology
|def="A cancer that is classified by the type of cell from which it is derived." [url:http\://cancerguide.org/basic.html, url:http\://en.wikipedia.org/wiki/Cancer]
|def="A cancer that is classified by the type of cell from which it is derived." [url:http\://cancerguide.org/basic.html, url:http\://en.wikipedia.org/wiki/Cancer]
|xref=
|xref=
Line 20: Line 20:
|located_in=
|located_in=
|part_of=
|part_of=
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|is_obsolete=
|preceded_by=
}}
}}

Revision as of 13:58, 11 June 2012

Name:cell type cancer
Namespace:disease_ontology
Definition:"A cancer that is classified by the type of cell from which it is derived." [url:http\://cancerguide.org/basic.html, url:http\://en.wikipedia.org/wiki/Cancer]
Created by:snadendla
Creation date:2011-06-13T03:28:50Z

Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data


Parents

is_a:DOID:162(cancer)



Children


is a:DOID:1115 (sarcoma),DOID:154 (mixed cell type cancer),DOID:1909 (melanoma),DOID:2994 (germ cell cancer),DOID:305 (carcinoma),DOID:3070 (malignant glioma),DOID:3350 (mesenchymal cell neoplasm)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

... further results Mouse (Mus musculus)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:0050687 (cell type cancer), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data


P-valueFFCPShort description
7.3e-52FFCP PHASE1:Hg19::chr9:97317348..97317379,+#_5476a99a4e92b3b9316ca013ad512187p1@uc004aus.1
7.3e-52FFCP PHASE2:Hg19::chr9:97317348..97317379,+#_5476a99a4e92b3b9316ca013ad512187p1@uc004aus.1
1.13e-48FFCP PHASE1:Hg19::chr7:156803329..156803362,-#_6c1bb7a6cf1312b0bcd487a9f91851b4p1@MNX1
1.13e-48FFCP PHASE2:Hg19::chr7:156803329..156803362,-#_6c1bb7a6cf1312b0bcd487a9f91851b4p1@MNX1
2.83e-48FFCP PHASE1:Hg19::chrX:153991088..153991168,+#_517cc3607d1ab1f7a8acfdf86512216fp1@DKC1
2.83e-48FFCP PHASE2:Hg19::chrX:153991088..153991168,+#_517cc3607d1ab1f7a8acfdf86512216fp1@DKC1
1.03e-46FFCP PHASE1:Hg19::chr12:20975472..20975489,+#_00e6f627fb3ec852eabd73be89c7ca29p@chr12:20975472..20975489, +
1.03e-46FFCP PHASE2:Hg19::chr12:20975472..20975489,+#_00e6f627fb3ec852eabd73be89c7ca29p@chr12:20975472..20975489, +
5.89e-46FFCP PHASE1:Hg19::chr20:57617831..57617909,-#_65f7279e60545754a324acde930dfe78p1@SLMO2
5.89e-46FFCP PHASE2:Hg19::chr20:57617831..57617909,-#_65f7279e60545754a324acde930dfe78p1@SLMO2
7.24e-46FFCP PHASE2:Hg19::chr7:1595871..1595896,-#_ee1f3964d0e3838cc1462a94e118c677p5@TMEM184A
7.24e-46FFCP PHASE1:Hg19::chr7:1595871..1595896,-#_ee1f3964d0e3838cc1462a94e118c677p5@TMEM184A
2.27e-45FFCP PHASE2:Hg19::chr8:120221345..120221393,+#_3d8132f22613bd0605544cd814d673bdp3@MAL2
2.27e-45FFCP PHASE1:Hg19::chr8:120221345..120221393,+#_3d8132f22613bd0605544cd814d673bdp3@MAL2
2.41e-45FFCP PHASE1:Hg19::chr11:1372935..1372952,+#_98f13140051ce854c8ac673ac299e9e3p@chr11:1372935..1372952, +
2.41e-45FFCP PHASE2:Hg19::chr11:1372935..1372952,+#_98f13140051ce854c8ac673ac299e9e3p@chr11:1372935..1372952, +
4.37e-45FFCP PHASE2:Hg19::chr3:180707436..180707451,-#_b19caebb5779f3793d0a43d63d5f97a7p2@DNAJC19
4.37e-45FFCP PHASE1:Hg19::chr3:180707436..180707451,-#_b19caebb5779f3793d0a43d63d5f97a7p2@DNAJC19
4.42e-45FFCP PHASE2:Hg19::chr3:172468505..172468582,+#_9662599a95471f6b573e63dcf691b7e0p1@ECT2
4.42e-45FFCP PHASE1:Hg19::chr3:172468505..172468582,+#_9662599a95471f6b573e63dcf691b7e0p1@ECT2
1.49e-44FFCP PHASE1:Hg19::chr15:56311466..56311511,+#_bdac417d2e3ac6bdf9d1cc3d43d4a5afp@chr15:56311466..56311511, +
1.49e-44FFCP PHASE2:Hg19::chr15:56311466..56311511,+#_bdac417d2e3ac6bdf9d1cc3d43d4a5afp@chr15:56311466..56311511, +
4.62e-44FFCP PHASE1:Hg19::chr12:20975516..20975562,+#_01c9631b772310c13886bcee2aaed2cep@chr12:20975516..20975562, +
4.62e-44FFCP PHASE2:Hg19::chr12:20975516..20975562,+#_01c9631b772310c13886bcee2aaed2cep@chr12:20975516..20975562, +
6.56e-42FFCP PHASE1:Hg19::chr15:78857870..78857897,+#_a884691d1058034c9cef3ce3e8473efbp1@CHRNA5
6.56e-42FFCP PHASE2:Hg19::chr15:78857870..78857897,+#_a884691d1058034c9cef3ce3e8473efbp1@CHRNA5
8.07e-42FFCP PHASE2:Hg19::chr7:96339167..96339197,-#_e6c57b5c5de9bb75947959265edc20fep2@SHFM1
8.07e-42FFCP PHASE1:Hg19::chr7:96339167..96339197,-#_e6c57b5c5de9bb75947959265edc20fep2@SHFM1
3.24e-41FFCP PHASE1:Hg19::chr1:154947148..154947175,+#_a9314f843ac941287985ff615e44b11ep1@CKS1B
3.24e-41FFCP PHASE2:Hg19::chr1:154947148..154947175,+#_a9314f843ac941287985ff615e44b11ep1@CKS1B
3.96e-41FFCP PHASE1:Hg19::chr5:34915805..34915847,+#_633a383f8705556aec1190ddd5bfb71dp1@BRIX1
3.96e-41FFCP PHASE2:Hg19::chr5:34915805..34915847,+#_633a383f8705556aec1190ddd5bfb71dp1@BRIX1
5.77e-41FFCP PHASE1:Hg19::chr17:36715685..36715749,-#_340e2e2094cbd602ba81d5b0182000bep3@SRCIN1
5.77e-41FFCP PHASE2:Hg19::chr17:36715685..36715749,-#_340e2e2094cbd602ba81d5b0182000bep3@SRCIN1
6.49e-41FFCP PHASE1:Hg19::chr7:105162652..105162709,-#_b5bf1ff3bc5994fb40ad509d3589db1ep1@PUS7
6.49e-41FFCP PHASE2:Hg19::chr7:105162652..105162709,-#_b5bf1ff3bc5994fb40ad509d3589db1ep1@PUS7
7.02e-41FFCP PHASE2:Hg19::chr2:54784868..54784919,+#_589ff22ede124956f3a7e112110534f3p@chr2:54784868..54784919, +
7.02e-41FFCP PHASE1:Hg19::chr2:54784868..54784919,+#_589ff22ede124956f3a7e112110534f3p@chr2:54784868..54784919, +
9.49e-41FFCP PHASE1:Hg19::chr2:238499725..238499747,-#_7a86feab6ec92a5007d5a1e4afaac56dp2@RAB17
9.49e-41FFCP PHASE2:Hg19::chr2:238499725..238499747,-#_7a86feab6ec92a5007d5a1e4afaac56dp2@RAB17
9.52e-41FFCP PHASE1:Hg19::chr13:109917833..109917866,+#_4f50b545d639545810a881464f1ec4c1p@chr13:109917833..109917866, +
9.52e-41FFCP PHASE2:Hg19::chr13:109917833..109917866,+#_4f50b545d639545810a881464f1ec4c1p@chr13:109917833..109917866, +
1.46e-40FFCP PHASE2:Hg19::chr8:124408630..124408647,-#_d0662a96d16202cb205a3ffff225c39ep2@ATAD2
1.46e-40FFCP PHASE1:Hg19::chr8:124408630..124408647,-#_d0662a96d16202cb205a3ffff225c39ep2@ATAD2
2.64e-40FFCP PHASE1:Hg19::chr4:57301645..57301675,-#_6e8e14de91aa3fd45dfd2b5d0c66ccb6p2@PPAT
2.64e-40FFCP PHASE2:Hg19::chr4:57301645..57301675,-#_6e8e14de91aa3fd45dfd2b5d0c66ccb6p2@PPAT
3.66e-40FFCP PHASE1:Hg19::chr5:37288836..37288849,-#_b2e8d775e4c6a1bb8f601a006fbe4f44p@chr5:37288836..37288849, -
3.66e-40FFCP PHASE2:Hg19::chr5:37288836..37288849,-#_b2e8d775e4c6a1bb8f601a006fbe4f44p@chr5:37288836..37288849, -
4.73e-40FFCP PHASE1:Hg19::chr22:22901636..22901715,-#_4dfe7d5511b645658a9e013c277138a9p1@PRAME
4.73e-40FFCP PHASE2:Hg19::chr22:22901636..22901715,-#_4dfe7d5511b645658a9e013c277138a9p1@PRAME
2.42e-39FFCP PHASE2:Hg19::chr15:69706740..69706754,+#_62031ce299723f757990be2bba890781p2@KIF23
2.42e-39FFCP PHASE1:Hg19::chr15:69706740..69706754,+#_62031ce299723f757990be2bba890781p2@KIF23
3.02e-39FFCP PHASE1:Hg19::chr7:11012953..11012969,+#_fd93e9825283cff3486fb8bc31274a63p@chr7:11012953..11012969, +
3.02e-39FFCP PHASE2:Hg19::chr7:11012953..11012969,+#_fd93e9825283cff3486fb8bc31274a63p@chr7:11012953..11012969, +
4.22e-39FFCP PHASE1:Hg19::chr5:37371163..37371231,-#_e87a340889538ac078ecac4b948756c4p1@NUP155
4.22e-39FFCP PHASE2:Hg19::chr5:37371163..37371231,-#_e87a340889538ac078ecac4b948756c4p1@NUP155
1.38e-38FFCP PHASE2:Hg19::chr7:56119449..56119492,+#_fc8c8b4bf62e8ccb6ad37deaf7ecad7ep1@CCT6A
1.38e-38FFCP PHASE1:Hg19::chr7:56119449..56119492,+#_fc8c8b4bf62e8ccb6ad37deaf7ecad7ep1@CCT6A
2.18e-38FFCP PHASE2:Hg19::chr17:38444115..38444194,+#_9263696c162d2231d123ddf9e9b18e19p1@CDC6
2.18e-38FFCP PHASE1:Hg19::chr17:38444115..38444194,+#_9263696c162d2231d123ddf9e9b18e19p1@CDC6
2.62e-38FFCP PHASE2:Hg19::chr7:1595831..1595858,-#_accb131c388a198f6c1ddbb4d5da638ap1@TMEM184A
2.62e-38FFCP PHASE1:Hg19::chr7:1595831..1595858,-#_accb131c388a198f6c1ddbb4d5da638ap1@TMEM184A
3.07e-38FFCP PHASE2:Hg19::chr17:62770351..62770363,-#_9e9b4deaf39a73b8d75223f7f44db7afp@chr17:62770351..62770363, -
3.07e-38FFCP PHASE1:Hg19::chr17:62770351..62770363,-#_9e9b4deaf39a73b8d75223f7f44db7afp@chr17:62770351..62770363, -
3.5e-38FFCP PHASE2:Hg19::chr2:70529150..70529179,-#_6b74e324c526b09133f3f2f842dc0905p1@FAM136A
3.5e-38FFCP PHASE1:Hg19::chr2:70529150..70529179,-#_6b74e324c526b09133f3f2f842dc0905p1@FAM136A
4.66e-38FFCP PHASE2:Hg19::chr12:54332608..54332636,+#_97931646101a64e4267a13fcd025e0efp1@HOXC13
4.66e-38FFCP PHASE1:Hg19::chr12:50419141..50419170,-#_97931646101a64e4267a13fcd025e0efp2@RACGAP1
4.66e-38FFCP PHASE2:Hg19::chr12:50419141..50419170,-#_97931646101a64e4267a13fcd025e0efp2@RACGAP1
4.66e-38FFCP PHASE1:Hg19::chr12:54332608..54332636,+#_97931646101a64e4267a13fcd025e0efp1@HOXC13
5.57e-38FFCP PHASE1:Hg19::chr12:118454500..118454585,+#_13d0f01f4c999c4a5f2364616fcd07d2p1@RFC5
5.57e-38FFCP PHASE2:Hg19::chr12:118454500..118454585,+#_13d0f01f4c999c4a5f2364616fcd07d2p1@RFC5
6.1e-38FFCP PHASE1:Hg19::chrX:27417088..27417131,-#_6de9539b6a44349d8d317ad1550a606ap1@ENST00000422048, p1@uc004dbt.2
6.1e-38FFCP PHASE2:Hg19::chrX:27417088..27417131,-#_6de9539b6a44349d8d317ad1550a606ap1@ENST00000422048, p1@uc004dbt.2
9.54e-38FFCP PHASE2:Hg19::chr11:66139128..66139152,-#_faee880c7e3dafefc5d2426004c8bda2p3@SLC29A2
9.54e-38FFCP PHASE1:Hg19::chr11:66139128..66139152,-#_faee880c7e3dafefc5d2426004c8bda2p3@SLC29A2
1.24e-37FFCP PHASE1:Hg19::chr2:198364552..198364576,-#_6f3958d46c2b8d00d02c43c18629dc16p1@HSPD1
1.24e-37FFCP PHASE2:Hg19::chr2:198364552..198364576,-#_6f3958d46c2b8d00d02c43c18629dc16p1@HSPD1
1.55e-37FFCP PHASE1:Hg19::chr2:174562443..174562467,+#_a67790d25df75c3fae09a7ab3afc5c68p@chr2:174562443..174562467, +
1.55e-37FFCP PHASE2:Hg19::chr2:174562443..174562467,+#_a67790d25df75c3fae09a7ab3afc5c68p@chr2:174562443..174562467, +
2.03e-37FFCP PHASE2:Hg19::chr2:29117521..29117569,+#_febc5301ad9d7acfac801688a82ea647p1@WDR43
2.03e-37FFCP PHASE1:Hg19::chr2:29117521..29117569,+#_febc5301ad9d7acfac801688a82ea647p1@WDR43
2.33e-37FFCP PHASE1:Hg19::chr17:43503012..43503035,-#_82c0944f083c2e52120ebdb31e2c3260p4@ARHGAP27
2.33e-37FFCP PHASE2:Hg19::chr17:43503012..43503035,-#_82c0944f083c2e52120ebdb31e2c3260p4@ARHGAP27
2.57e-37FFCP PHASE1:Hg19::chr16:2955389..2955405,-#_616eadb0cd1164efd51f9947857688f1p@chr16:2955389..2955405, -
2.57e-37FFCP PHASE2:Hg19::chr16:2955389..2955405,-#_616eadb0cd1164efd51f9947857688f1p@chr16:2955389..2955405, -
3.09e-37FFCP PHASE1:Hg19::chr1:235268802..235268805,-#_be58c527b0fde018746d6447849972dep@chr1:235268802..235268805, -
3.09e-37FFCP PHASE2:Hg19::chr1:235268802..235268805,-#_be58c527b0fde018746d6447849972dep@chr1:235268802..235268805, -
4.54e-37FFCP PHASE2:Hg19::chr5:10250349..10250362,+#_2d8ec77f3e3b38a639bb60ed5abb7351p2@CCT5
4.54e-37FFCP PHASE1:Hg19::chr5:10250349..10250362,+#_2d8ec77f3e3b38a639bb60ed5abb7351p2@CCT5
5.03e-37FFCP PHASE1:Hg19::chr3:194040598..194040638,-#_a712dcc4ebc6ef017cd020b53657a059p@chr3:194040598..194040638, -
5.03e-37FFCP PHASE2:Hg19::chr3:194040598..194040638,-#_a712dcc4ebc6ef017cd020b53657a059p@chr3:194040598..194040638, -
8.27e-37FFCP PHASE2:Hg19::chr7:1595804..1595828,-#_f2fda5d569a0d61899984d16d3745198p3@TMEM184A
8.27e-37FFCP PHASE1:Hg19::chr7:1595804..1595828,-#_f2fda5d569a0d61899984d16d3745198p3@TMEM184A
1.08e-36FFCP PHASE2:Hg19::chr10:96363899..96363904,+#_2f4812cba8b76987d543a2adf63419f1p@chr10:96363899..96363904, +
1.08e-36FFCP PHASE1:Hg19::chr10:96363899..96363904,+#_2f4812cba8b76987d543a2adf63419f1p@chr10:96363899..96363904, +
1.73e-36FFCP PHASE1:Hg19::chr18:47376197..47376227,-#_8552cdedfcfc121adb8a183e8f88e8cep2@MYO5B
1.73e-36FFCP PHASE2:Hg19::chr18:47376197..47376227,-#_8552cdedfcfc121adb8a183e8f88e8cep2@MYO5B
1.81e-36FFCP PHASE1:Hg19::chr13:114103443..114103479,-#_43a101d9ebdcc8ce216dbdbec85d4c98p2@ADPRHL1
1.81e-36FFCP PHASE2:Hg19::chr13:114103443..114103479,-#_43a101d9ebdcc8ce216dbdbec85d4c98p2@ADPRHL1